Categorie -wet- en regelgeving

bv CGR, GDPR

Leqembi

wet- en regelgeving

FDA adcomm recommends Alzheimer’s drug Leqembi for full approval

12 juni 2023

MMM - Medical Marketing and Media

US FDA accepts for review sBLA for Merck's Keytruda in combo with chemotherapy to treat advanced or unresectable biliary tract cancer

wet- en regelgeving

US FDA accepts for review sBLA for Merck’s Keytruda in combo with chemotherapy to treat advanced or unresectable biliary tract cancer

9 juni 2023

Pharma Biz

European Commission authorises GSK's RSV vaccine

wet- en regelgeving

European Commission authorises GSK’s RSV vaccine, Arexvy for older adults

8 juni 2023

Pharma Biz

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Wednesday, June 7, 2023

8 juni 2023

MMM - Medical Marketing and Media

Fennec Pharma gets European marketing authorization for Pedmarqsi to reduce the risk of hearing loss

wet- en regelgeving

Fennec Pharma gets European marketing authorization for Pedmarqsi to reduce the risk of hearing loss in paediatric oncology patients

8 juni 2023

Pharma Biz

NICE approves first treatment for obstructive HCM for NHS use

wet- en regelgeving

NICE approves first treatment for obstructive HCM for NHS use

5 juni 2023

InPharm.com

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer